Integra buys NMT neuroscience line for $12 million
This article was originally published in Clinica
Executive Summary
Integra LifeSciences is to buy various parts of NMT Medical's neurosciences business for $12 million in cash. The move allows NMT to concentrate on its core cardiac business.